Skip to main content

The Flatiron Health acquisition is a shot in the arm for Roche's oncology real-world evidence needs

By Forbes  
   February 28, 2018

Why Roche paid $1.9 billion for a 5-year-old company. Earlier this month, Roche, a global pharmaceutical giant, acquired Flatiron Health, an oncology-focused electronic health records (EHR) company, for $1.9 billion.

Full story


Get the latest on healthcare leadership in your inbox.